CD73 Attenuates Alcohol-Induced Liver Injury and Inflammation via Blocking TLR4/MyD88/NF-κB Signaling Pathway

References

• Wang Y, Liu Y, Kirpich I, et al. Lactobacillus rhamnosus GG reduces hepatic TNFα production and inflammation in chronic alcohol-induced liver injury. J Nutr Biochem. 2013;24(9):1609–1615. doi:10.1016/j.jnutbio.2013.02.001
   PubMed Web of Science ®Google Scholar
• Arsene D, Farooq O, Bataller R. New therapeutic targets in alcoholic hepatitis. Hepatol Int. 2016;10(4):538–552. doi:10.1007/s12072-015-9701-6
   PubMed Web of Science ®Google Scholar
• Liangpunsakul S, Haber P, McCaughan G. Alcoholic liver disease in Asia, Europe, and North America. Gastroenterology. 2016;150(8):1786–1797. doi:10.1053/j.gastro.2016.02.043.
   PubMed Web of Science ®Google Scholar
• Wang FS, Fan JG, Zhang Z, Gao B, Wang HY. The global burden of liver disease: the major impact of China. Hepatology. 2015;60(6):2099–2108.
   Web of Science ®Google Scholar
• Addolorato G, Mirijello A, Barrio P, Gual A. Treatment of alcohol use disorders in patients with alcoholic liver disease. J Hepatol. 2016;65(3):618–630. doi:10.1016/j.jhep.2016.04.029
   PubMed Web of Science ®Google Scholar
• Gao B, Bataller R. Alcoholic liver disease: pathogenesis and new therapeutic targets. Gastroenterology. 2011;141(5):1572–1585. doi:10.1053/j.gastro.2011.09.002
   PubMed Web of Science ®Google Scholar
• Gupta P, Srivastav S, Saha S, Das PK, Ukil A. Leishmania donovani inhibits macrophage apoptosis and pro-inflammatory response through AKT-mediated regulation of β-catenin and FOXO-1. Cell Death Differ. 2016;23(11):1815–1826. doi:10.1038/cdd.2016.101
   PubMed Web of Science ®Google Scholar
• Zhao Y-Y, Zeng T, Xie K-Q, et al. Associations between the tumor necrosis factor-alpha gene and interleukin-10 gene polymorphisms and risk of alcoholic liver disease: a meta-analysis. Clin Res Hepatol Gas. 2016;40(4):428–439. doi:10.1016/j.clinre.2015.10.007
   PubMed Web of Science ®Google Scholar
• Kasztelan-Szczerbińska B, Surdacka A, Celiński K, et al. Prognostic significance of systemic inflammatory and immune balance in alcoholic liver disease with a focus on gender-related differences. PLoS One. 2015;10(6):e0128347. doi:10.1371/journal.pone.0128347
   PubMed Web of Science ®Google Scholar
• Kawaratani H, Tsujimoto T, Douhara A, et al. The effect of inflammatory cytokines in alcoholic liver disease. Mediat Inflamm. 2013;2013:1–10. doi:10.1155/2013/495156
   Web of Science ®Google Scholar
• Xu T, Pan LX, Ge YX, et al. TMEM88 mediates inflammatory cytokines secretion by regulating JNK/P38 and canonical Wnt/β-catenin signaling pathway in LX-2 cells. Inflammopharmacology. 2018;26(5):1339–1348. doi:10.1007/s10787-017-0419-z
   PubMed Web of Science ®Google Scholar
• Schafer C, Parlesak A, Schütt C, et al. Concentrations of lipopolysaccharide-binding protein, bactericidal/permeability-increasing protein, soluble CD14 and plasma lipids in relation to endotoxaemia in patients with alcoholic liver disease. Alcohol Alcohol. 2002;37:81–86. doi:10.1093/alcalc/37.1.81
   PubMed Web of Science ®Google Scholar
• Petrasek J, Csak T, Szabo G. Toll-like receptors in liver disease. Adv Clin Chem. 2013;59:155–201. doi:10.1016/b978-0-12-405211-6.00006-1
   PubMed Web of Science ®Google Scholar
• Bessone F, Razori MV, Roma MG. Molecular pathways of nonalcoholic fatty liver disease development and progression. Cell Mol Life Sci. 2019;76:99–128.
   PubMed Web of Science ®Google Scholar
• Machado MV, Diehl AM. Pathogenesis of nonalcoholic steatohepatitis. Gastroenterology. 2016;150(8):1769–1777. doi:10.1053/j.gastro.2016.02.066
   PubMed Web of Science ®Google Scholar
• Hua F, Wang J, Ishrat T, et al. Genomic profile of Toll-like receptor pathways in traumatically brain-injured mice: effect of exogenous progesterone. J Neuroinflamm. 2011;8(1):42. doi:10.1186/1742-2094-8-42
   PubMed Web of Science ®Google Scholar
• Ju M, Liu B, He Het al. MicroRNA-27a alleviates LPS-induced acute lung injury in mice via inhibiting inflammation and apoptosis through modulating TLR4/MyD88/NF-κB pathway. Cell Cycle. 2018;17:2001–2018.
   PubMed Web of Science ®Google Scholar
• Neo SY, Yang Y, Record J, et al. CD73 immune checkpoint defines regulatory NK cells within the tumor microenvironment. J Clin Invest. 2020;130(3):1185–1198. doi:10.1172/JCI128895
   PubMed Web of Science ®Google Scholar
• Ma XL, Shen MN, Hu B, et al. CD73 promotes hepatocellular carcinoma progression and metastasis via activating PI3K/AKT signaling by inducing Rap1-mediated membrane localization of P110β and predicts poor prognosis. J Hematol Oncol. 2019;12(1). doi:10.1186/s13045-019-0724-7
   Web of Science ®Google Scholar
• Stagg J, Beavis PA, Divisekera U, Liu MCP, Smyth MJ. CD73-deficient mice are resistant to carcinogenesis. Cancer Res. 2012;72(9):2190. doi:10.1158/0008-5472.CAN-12-0420
   PubMed Web of Science ®Google Scholar
• Yu J, Wang X, Lu Q, et al. Extracellular 5′‐nucleotidase (CD73) promotes human breast cancer cells growth through AKT/GSK‐3β/β‐catenin/cyclinD1 signaling pathway. Int J Cancer. 2018;142(5):959–967. doi:10.1002/ijc.31112
   PubMed Web of Science ®Google Scholar
• Li H, Karmouty-Quintana H, Chen NY, Mills T, Davies J. Loss of CD73-mediated extracellular adenosine production exacerbates inflammation and abnormal alveolar development in newborn mice exposed to prolonged hyperoxia. Pediatr Res. 2017;82(6):1039–1047. doi:10.1038/pr.2017.176
   Web of Science ®Google Scholar
• Caiazzo E, Cerqua I, Riemma MA, Turiello R, Cicala C. Exacerbation of allergic airway inflammation in mice lacking ECTO-5′-nucleotidase (CD73). Front Pharmacol. 2020;11. doi:10.3389/fphar.2020.589343
   PubMed Web of Science ®Google Scholar
• Bradaschia-Correa V, Josephson AM, Egol AJ, et al. Ecto-5ʹ-nucleotidase (CD73) regulates bone formation and remodeling during intramembranous bone repair in aged mice. Tissue Cell. 2017;49:545–551.
   PubMed Web of Science ®Google Scholar
• Sun-sang JS, Li L, Huang L, et al. Proximal tubule CD73 is critical in renal ischemia-reperfusion injury protection. J Am Soc Nephrol. 2017;28:888–902. doi:10.1681/ASN.2016020229
   PubMed Web of Science ®Google Scholar
• Liu Z, Jia W, Jiang T, Dai J, Shuai C, Lv X. Regulation of CD39 expression in ATP-P2Y2R-mediated alcoholic liver steatosis and inflammation. Int Immunopharmacol. 2019;77:105915. doi:10.1016/j.intimp.2019.105915
   PubMed Web of Science ®Google Scholar
• Hong Y, Yiping S, Shasha S, et al. Protective effects of dioscin against lipopolysaccharide-induced acute lung injury through inhibition of oxidative stress and inflammation. Front Pharmacol. 2017;8:120. doi:10.3389/fphar.2017.00120
   PubMed Web of Science ®Google Scholar
• Zhao G, Zhang T, Ma X, et al. Oridonin attenuates the release of pro-inflammatory cytokines in lipopolysaccharide-induced RAW264.7 cells and acute lung injury. Oncotarget. 2017;8(40):68153. doi:10.18632/oncotarget.19249
   PubMedGoogle Scholar
• Xu MJ, Zhou Z, Parker R, Gao B. Targeting inflammation for the treatment of alcoholic liver disease. Pharmacol Ther. 2017;180:77. doi:10.1016/j.pharmthera.2017.06.007
   PubMed Web of Science ®Google Scholar
• Louvet A, Mathurin P. Alcoholic liver disease: mechanisms of injury and targeted treatment. Nat Rev Gastroenterol Hepatol. 2015;12(4):231–242. doi:10.1038/nrgastro.2015.35
   PubMed Web of Science ®Google Scholar
• Luisa V, Mikhaïl A, Van H, et al. Targeting myeloid-derived cells: new frontiers in the treatment of non-alcoholic and alcoholic liver disease. Front Immunol. 2019;10:563.
   PubMed Web of Science ®Google Scholar
• Saha B, Momen‐Heravi F, Furi Iet al. Extracellular vesicles from mice with alcoholic liver disease carry a distinct protein cargo and induce macrophage activation through heat shock protein 90. Hepatology. 2018;67:1986–2000.
   PubMed Web of Science ®Google Scholar
• Singal AK, Shah VH. Therapeutic strategies for the treatment of alcoholic hepatitis. Semin Liver Dis. 2016;36(01):56–68. doi:10.1055/s-0036-1571297
   PubMed Web of Science ®Google Scholar
• Voican CS, Perlemuter G, Naveau S. Mechanisms of the inflammatory reaction implicated in alcoholic hepatitis: 2011 update. Clin Res Hepatol Gastroenterol. 2011;35(6):465–474. doi:10.1016/j.clinre.2011.01.017
   PubMed Web of Science ®Google Scholar
• Luo W, Xu Q, Wang Q, Wu H, Hua J. Effect of modulation of PPAR-γ activity on Kupffer cells M1/M2 polarization in the development of non-alcoholic fatty liver disease. Sci Rep. 2017;7(1):44612. doi:10.1038/srep44612
   PubMed Web of Science ®Google Scholar
• Shaughnessy LM, Swanson JA. The role of the activated macrophage in clearing Listeria monocytogenes infection. Front Biosci. 2007;12:2683. doi:10.2741/2364
   PubMed Web of Science ®Google Scholar
• Jouanguy E, Döffinger R, Dupuis S, et al. IL-12 and IFN-gamma in host defense against mycobacteria and salmonella in mice and men. Curr Opin Immunol. 1999;11(3):346–351. doi:10.1016/S0952-7915(99)80055-7
   PubMed Web of Science ®Google Scholar
• Park J, Shao M, Kim MY, et al. An endoplasmic reticulum protein, Nogo‐B, facilitates alcoholic liver disease through regulation of Kupffer cell polarization. Hepatology. 2017;65:1720–1734. doi:10.1002/hep.29051
   PubMed Web of Science ®Google Scholar
• Pan G, Zhao Z, Tang C, et al. Soluble fibrinogen-like protein 2 ameliorates acute rejection of liver transplantation in rat via inducing Kupffer cells M2 polarization. Cancer Med. 2018;7(7):3168–3177. doi:10.1002/cam4.1528
   PubMed Web of Science ®Google Scholar
• Gual P, Pecker F, Bonnafous S, et al. M2 Kupffer cells promote M1 Kupffer cell apoptosis: a protective mechanism against alcoholic and nonalcoholic fatty liver disease. Hepatology. 2014;59:130–142. doi:10.1002/hep.26607
   PubMed Web of Science ®Google Scholar
• Mills JH, Thompson LF, Mueller C, et al. CD73 is required for efficient entry of lymphocytes into the central nervous system during experimental autoimmune encephalomyelitis. Proc Natl Acad Sci U S A. 2008;105(27):9325–9330. doi:10.1073/pnas.0711175105
   PubMed Web of Science ®Google Scholar
• Zhou S, Liu G, Guo J, Kong F, Chen S, Wang Z. Pro-inflammatory effect of downregulated CD73 expression in EAE astrocytes. Front Cell Neurosci. 2019;13. doi:10.3389/fncel.2019.00233
   Web of Science ®Google Scholar
• Zernecke A. CD73/Ecto-5′-nucleotidase protects against vascular inflammation and neointima formation. Circulation. 2006;113(17):2120–2127. doi:10.1161/CIRCULATIONAHA.105.595249
   PubMed Web of Science ®Google Scholar
• Li LY, Yang CC, Li SW, Liu YM, Xu T. TMEM88 modulates the secretion of inflammatory factors by regulating YAP signaling pathway in alcoholic liver disease. Inflamm Res. 2020;69(8):789–800. doi:10.1007/s00011-020-01360-y
   PubMed Web of Science ®Google Scholar
• Zanin RF, Braganhol E, Bergamin LS, et al. Differential macrophage activation alters the expression profile of NTPDase and Ecto-5’-Nucleotidase. PLoS One. 2012;7(2):e31205. doi:10.1371/journal.pone.0031205
   PubMed Web of Science ®Google Scholar
• Beninson LA, Fleshner M. Exosomes in fetal bovine serum dampen primary macrophage IL-1 beta response to lipopolysaccharide (LPS) challenge. Immunol Lett. 2015;163(2):187–192. doi:10.1016/j.imlet.2014.10.019
   PubMed Web of Science ®Google Scholar
• Chen SN, Tan Y, Xiao XC, et al. Deletion of TLR4 attenuates lipopolysaccharide-induced acute liver injury by inhibiting inflammation and apoptosis. Acta Pharmacol Sin. 2021;42(10):1610–1619. doi:10.1038/s41401-020-00597-x
   PubMed Web of Science ®Google Scholar
• Yin H, Huang L, Ouyang T, Chen L. Baicalein improves liver inflammation in diabetic db/db mice by regulating HMGB1/TLR4/NF-κB signaling pathway. Int Immunopharmacol. 2018;55:55–62. doi:10.1016/j.intimp.2017.12.002
   PubMed Web of Science ®Google Scholar